Skip to main content
AFJK
NASDAQ Real Estate & Construction

Aimei Shareholders Approve 12-Month Extension; 841,629 Shares Redeemed, Trust Falls to $2.45M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Real Estate
Sentiment info
Negative
Importance info
8
Price
$11.9
Mkt Cap
$37.679M
52W Low
$6.75
52W High
$130.37
52W Position info
76% above low
Off High info
91% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

AFJK sits 76% above its 52-week low of $6.75.

Summary

Aimei shareholders approved pushing the SPAC deadline to December 6, 2027, but 841,629 shares redeemed at about $12.33 each, cutting the Trust Account to roughly $2.45M and shares outstanding to 2,324,703.


Key Events · Corporate Governance and Compliance · AFJK

  • Extension Approved Through December 2027

    At the November 10, 2026 extraordinary general meeting, holders approved amending Article 35.2 to extend the business combination deadline from December 6, 2026 to December 6, 2027, with 2,757,268 votes for and 5,377 against.

  • 841,629 Shares Redeemed at $12.33

    Public shareholders redeemed 841,629 shares for approximately $10,377,384, or about $12.33 per share, leaving the Trust Account at approximately $2,450,031.

  • Share Count Falls to 2,324,703

    Ordinary shares outstanding drop from 3,166,332 on the October 2, 2026 record date to 2,324,703 after redemptions — about 26.6% of the register exited (841,629 / 3,166,332).

  • Monthly Extension Deposits Still Required

    Each one-month extension still requires the lesser of $80,000 for all remaining public shares or $0.033 per outstanding public share, funded by the Sponsor.


Analysis · AFJK · Real Estate & Construction

The extension passed easily, but the cost is severe: holders of 841,629 Public Shares — roughly a quarter of the register — took the $12.33 redemption instead of staying in. That drains the Trust Account from about $12.8M to roughly $2.45M, leaving a shell with 2,324,703 shares outstanding and very little cash to attract or close a target. The November 14 letter of intent with the Memphis drug developer is now the whole thesis, and it is non-binding with a trust balance this thin. The auditor ratification is routine by comparison.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AFJK was trading at $11.90 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $37.7M. The 52-week trading range was $6.75 to $130.37. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AFJK - Latest Insights

AFJK
Nov 17, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.84
Real-time Price: $12.20 info
Change: +$0.360 (+3%) info
Market Cap: $37.679M info
AFJK
Oct 09, 2026, 8:00 AM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $12.02
Real-time Price: $12.20 info
Change: +$0.180 (+1%) info
Market Cap: $37.679M info
AFJK
Aug 25, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $12.28
Real-time Price: $12.20 info
Change: -$0.080 (-0.65%) info
Market Cap: $37.679M info
AFJK
Aug 13, 2026, 8:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.99
Real-time Price: $12.20 info
Change: +$0.210 (+2%) info
Market Cap: $37.679M info
AFJK
Jul 08, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $17.99
Real-time Price: $12.20 info
Change: -$5.79 (-32%) info
Market Cap: $37.679M info